论文部分内容阅读
目的:探讨研究孟鲁司特治疗毛细支气管炎的疗效。方法:随机选取在我院60例毛细支气管患儿为研究对象,对照组30例患儿给予常规综合治疗,实验组30例在对照组的基础上加用孟鲁司特钠治疗,2周后记录两组患儿喘息、咳嗽持续次数及时间以及住院时间等,比较两组患儿的临床治疗效果。结果:实验组30例患儿喘息、咳嗽的发作次数较治疗前有明显减少。实验组30例患儿治疗效果比对照组30例患儿治疗效果更为显著,实验组总有效率为93.3%明显高出对照组总有效率76.6%。结论:孟鲁司特钠可以提高毛细支气管炎的临床治疗效果,缩短患儿的住院时间,改善患儿咳嗽、喘息症状,具有一定的临床推广价值。
Objective: To investigate the efficacy of montelukast in the treatment of bronchiolitis. Methods: Sixty patients with bronchiolitis in our hospital were randomly selected for the study. Thirty children in the control group were given conventional treatment. The experimental group was treated with montelukast sodium on the basis of the control group. After two weeks Two groups of children with wheezing, cough duration and duration of hospital stay were recorded, and the clinical effects of two groups were compared. Results: In the experimental group, the number of wheezing and coughing episodes in 30 children was significantly lower than that before treatment. The therapeutic effect of 30 cases of experimental group was more significant than that of 30 cases of control group. The total effective rate was 93.3% in experimental group and 76.6% in control group. Conclusion: Montelukast sodium can improve the clinical therapeutic effect of bronchiolitis, shorten the hospitalization time of children, and improve the symptoms of cough and wheeze in children, and have a certain value of clinical popularization.